Skip to main content

Table 6 Comparison of adjacent segment degeneration

From: Comparison of safety and efficacy of posterior lumbar interbody fusion (PLIF) and modified transforaminal lumbar interbody fusion (M-TLIF) in the treatment of single-segment lumbar degenerative diseases

 

PLIF (n = 74)

M-TLIF (n = 74)

P

Lumber disc herniation, n (%)

  

0.257

 No

60 (81.08%)

65 (87.84%)

 

 Yes

14 (18.92%)

9 (12.16%)

 

Lumbar Spinal Stenosis, n (%)

  

1.000

 No

72 (97.30%)

73 (98.65%)

 

 Yes

2 (2.70%)

1 (1.35%)

 

Spondylolisthesis, n (%)

  

0.612

 No

73 (98.65%)

71 (95.95%)

 

 Yes

1 (1.35%)

3 (4.05%)

 

Thoracolumbar fracture, n (%)

  

0.120*

 No

74 (100%)

70 (94.59%)

 

 Yes

0

4 (5.41%)

 

Osteophyte of anterior edge of vertebral body (> II grade), n (%)

  

0.029

 No

62 (83.78%)

71 (95.95%)

 

 Yes

12 (16.22%)

3 (4.05%)

 

Osteophyte of posterior margin of vertebral body, n (%)

  

0.366

 No

66 (89.19%)

70 (94.59%)

 

 Yes

8 (10.81%)

4 (5.41%)

 

Ligament calcification

  

1.000

 No

69 (93.24%)

70 (94.59%)

 

 Yes

5 (6.76%)

4 (5.41%)

 

Intervertebral disc cavity

  

1.000

 No

72 (97.30%)

73 (98.65%)

 

 Yes

2 (2.70%)

1 (1.35%)

 

Modic changes

  

1.000

 No

73 (98.65%)

73 (98.65%)

 

 Yes

1 (1.35%)

1 (1.35%)

 
  1. *Results from fisher’s exact test. PLIF, Posterior lumbar interbody fusion. M-TLIF, Modified transforaminal lumbar interbody fusion